UroGen Pharma
URGN
URGN
149 hedge funds and large institutions have $545M invested in UroGen Pharma in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 45 increasing their positions, 41 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
10% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 41
3.96% less ownership
Funds ownership: 90.27% → 86.31% (-4%)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
149
Holding in Top 10
4
Calls
$35.4M
Puts
$14.1M
Top Buyers
| 1 | +$29.9M | |
| 2 | +$22.2M | |
| 3 | +$19.7M | |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$19M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$13.7M |
Top Sellers
| 1 | -$48.2M | |
| 2 | -$35.5M | |
| 3 | -$23.8M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$18.6M |
| 5 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
-$15.8M |
